Article
Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer.
European cytokine network - 1 Dec 2023
Haghshenas Mohammad Reza, Shiravani Zahra, Samare-Najaf Mohammad, Khansalar Soolmaz, Razavinasab Seyed Ali, Ghaderi Abbas, Jamali Navid
Abstract excerpt
Endometrial cancer (EC) is recognized as the second most common type of cancer among women. Interleukin-37 (IL-37) is a recently discovered member of the IL-1 cytokine family characterized by its anti-inflammatory properties, which are believed to have both anti-tumour and tumorigenic effects. However, the precise role of IL-37 in the development of EC remains largely unknown. In the current study, we aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
